Thomas P Lodise

53PUBLICATIONS
77CO-AUTHORS
Disease surveillanceEconomic models and forecastingMedical infection agents (incl. prions)Epidemiological methodsCross-sectional analysis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (53)

|Jun 12, 2026
Clinical Impact of the BIOFIRE® FILMARRAY® Pneumonia Panel in the Veterans Affairs Healthcare System: A Difference-in-Differences Study.

|Jun 11, 2026
Toward the Future: A Race-Agnostic, Bayesian Approach to Defining Glomerular Filtration for Personalized Drug Dosing.

|Sep 18, 2025
Comparison of early treatment with ceftolozane/tazobactam versus polymyxin-based therapy of pneumonia due to MDR <i>Pseudomonas</i> <i>aeruginosa</i> (PUMA).

Thomas P Lodise, Jae Min, Brian H Nathanson

|Sep 01, 2025
Association Between Duration of Candidemia and Clinical and Healthcare Resource Utilization Outcomes Among Hospitalized Adult Patients With Candidemia Who Received Empiric Treatment With an Echinocandin Across United States Hospitals.

Thomas P Lodise, Kevin W Garey, Jalal A Aram

|Jun 26, 2025
Pivmecillinam for Treatment of Uncomplicated Urinary Tract Infection: New Efficacy Analysis.

Thomas P Lodise, Anita F Das, Niels Frimodt-Møller

|Jun 12, 2025
Population pharmacokinetic analyses for telavancin using data from healthy subjects and patients with infections.

Scott A Van Wart, M Courtney Safir, Sujata M Bhavnani

Pageof 9

Frequent Collaborators

8 joint publications

J Nicholas O'Donnell

7 joint publications

Marc Scheetz

5 joint publications

Nimish Patel

4 joint publications

Michael J Rybak